Palmatine alleviates cardiac fibrosis by inhibiting fibroblast activation through the STAT3 pathway
- 11 February 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 967, 176395
Abstract
No abstract availableKeywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province
This publication has 42 references indexed in Scilit:
- Mechanisms of physiological and pathological cardiac hypertrophyNature Reviews Cardiology, 2018
- IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosisCardiovascular Research, 2018
- Palmatine attenuates isoproterenol-induced pathological hypertrophy via selectively inhibiting HDAC2 in ratsInternational Journal of Immunopathology and Pharmacology, 2017
- Network‐based Approaches in PharmacologyMolecular Informatics, 2017
- The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the HeartJournal of Clinical Medicine, 2017
- Redefining the identity of cardiac fibroblastsNature Reviews Cardiology, 2017
- Cardiotoxicity evaluation of nine alkaloids from Rhizoma CoptisHuman & Experimental Toxicology, 2017
- Rhizoma Coptidis: A Potential Cardiovascular Protective AgentFrontiers in Pharmacology, 2016
- Tryptase activates isolated adult cardiac fibroblasts via protease activated receptor-2 (PAR-2)Journal of Cell Communication and Signaling, 2011
- Palmatine from Coptidis rhizoma reduces ischemia–reperfusion-mediated acute myocardial injury in the ratFood and Chemical Toxicology, 2009